Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Department of Urology, Mayo Clinic, Phoenix, Arizona.
J Urol. 2023 Sep;210(3):492-499. doi: 10.1097/JU.0000000000003559. Epub 2023 May 30.
Our goal was to compare outcomes of early vs delayed transurethral surgery for benign prostatic hyperplasia after an episode of acute urinary retention compared to men without preoperative acute retention.
We conducted a retrospective cohort analysis using data from the New York Statewide Planning and Research Cooperative System from 2002-2016. We identified men ≥40 years old who underwent primary ambulatory transurethral resection or photoselective vaporization of the prostate, assessing surgical failure as time to reoperation or recatheterization. We categorized presurgical acute urinary retention by number of episodes: none (reference), 1, or ≥2 precatheterizations, and time from first retention episode to surgery: none (reference), 0-6 months, and >6 months. We used Fine-Gray competing-risk models to predict surgical failure at 10 years, with presurgical acute retention as the primary predictor, adjusted for age, race, insurance, Charlson Comorbidity Index score, preoperative urinary infection, and procedure type, with death as the competing risk.
Among 17,474 patients undergoing transurethral surgery, 10% had preoperative acute retention with a median time to surgery of 2.4 months (IQR: 1-18). Among men with preoperative retention, 37% had ≥6 months of delay to surgery. The 10-year cumulative treatment failure rate was 17.2% among catheter naïve men vs 34.0% with ≥2 precatheterizations and 32.9% with ≥6 months delay to surgery. Delays from catheterization to surgery were associated with higher rates of treatment failure (<6 months SHR 1.49, < .001; ≥6 months SHR 2.11, < .001) vs catheter naïve men.
Preoperative acute urinary retention and delay to surgery once catheterized are associated with poorer long-term postoperative outcomes after surgery for benign prostatic hyperplasia.
我们的目标是比较急性尿潴留后早期与延迟经尿道前列腺切除术治疗良性前列腺增生的结果,并与术前无急性尿潴留的男性进行比较。
我们使用 2002 年至 2016 年期间来自纽约州规划与研究合作系统的数据进行了回顾性队列分析。我们确定了年龄≥40 岁、接受门诊经尿道前列腺切除术或前列腺光选择性汽化术的男性,将手术失败定义为再次手术或重新置管的时间。我们根据术前急性尿潴留的发作次数将其分类:无(参考)、1 次或≥2 次置管前、从首次尿潴留发作到手术的时间:无(参考)、0-6 个月和>6 个月。我们使用 Fine-Gray 竞争风险模型预测 10 年时的手术失败,以术前急性尿潴留为主要预测因素,调整年龄、种族、保险、Charlson 合并症指数评分、术前尿路感染和手术类型,以死亡为竞争风险。
在 17474 例接受经尿道手术的患者中,10%有术前急性尿潴留,中位手术时间为 2.4 个月(IQR:1-18)。在术前有尿潴留的男性中,37%有≥6 个月的手术延迟。在导管未使用的男性中,10 年累积治疗失败率为 17.2%,而≥2 次置管和≥6 个月手术延迟的男性分别为 34.0%和 32.9%。从置管到手术的延迟与更高的治疗失败率相关(<6 个月 SHR 1.49,<.001;≥6 个月 SHR 2.11,<.001),与导管未使用的男性相比。
术前急性尿潴留和置管后延迟手术与经尿道前列腺切除术治疗良性前列腺增生后的长期术后结果较差有关。